
Aaltramed Pharma Private Limited
This company specializes in manufacturing and dealing with a wide range of chemicals and pharmaceutical products.
This company specializes in manufacturing and dealing with a wide range of chemicals and pharmaceutical products.
Hyderabad, Telangana, India
+91-XXXXXXXXXX
U24100TG2020PTC143785
143785
Private Limited Indian Non-Government Company
11 Sep 2020
-
-
Unlisted
Roc Hyderabad
Name | Designation | Appointment Date | Status |
---|---|---|---|
Pandu Muttavarapu ![]() | Director | 11-Sep-2020 | Current |
Prabhakar Gutha ![]() | Director | 11-Sep-2020 | Current |
Enhance accessibility to Aaltramed Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Aaltramed Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Prabhakar Gutha is a mutual person
Prabhakar Gutha is a mutual person
Prabhakar Gutha is a mutual person
Prabhakar Gutha is a mutual person
Prabhakar Gutha is a mutual person
Prabhakar Gutha is a mutual person
There are no open charges registered against the company as per our records.
Aaltramed Pharma has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aaltramed Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aaltramed Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Prabhakar Rao Gutha was appointed as a Director was appointed as a Director on 11 Sep 2020 & has been associated with this company since 4 years 6 months .
Pandu Ranga Rao Muttavarapu was appointed as a Director was appointed as a Director on 11 Sep 2020 & has been associated with this company since 4 years 6 months .
Aaltramed Pharma Private Limited was registered on 11 Sep 2020 with Roc Hyderabad & aged 4 years 6 months as per MCA records.
Aaltramed Pharma Private Limited was incorporated on 11 Sep 2020.
The authorized share capital of Aaltramed Pharma Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 2 directors are associated with Aaltramed Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Aaltramed Pharma Private Limited is Plot No 137 Brindavan Colony, Near Jntu Kukatpally Nizampet Road, Hyderabad, Telangana, India, 500085.
The corporate identification number (CIN) of Aaltramed Pharma Private Limited is U24100TG2020PTC143785 and the company number is 143785 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.